Home
biotech

biotech

Exclusive: Biotech startup Profluent says it has found “scaling laws” for AI models for protein design
Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in funding and a partnership with Bristol Myers Squibb